Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nikolai Loft

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Dermatology (Basel, Switzerland)|March 3, 2026
Screening practice of cardiovascular risk and psoriatic arthritis among patients with psoriasis in primary careYasmine Khaldi, Lone Skov, Claus Zachariae, et al.
Dermatologic Therapy|August 21, 2021
Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasisNikolai Loft, Anne Bregnhøj, Simon Fage, et al.
International Journal of Dermatology|October 29, 2025
Risk of Dyslipidemia Associated With Oral Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsDaniel Isufi, Niloufar Javanmardi, Mikkel Bak Jensen, et al.
International Journal of Molecular Sciences|September 27, 2025
The Association Between Genetics and Response to Treatment with Biologics in Patients with PsoriasisNikolai Loft, Sule Altintas, Rownaq Al-Sofi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2024
Psychological burden, anxiety, depression and quality of life in patients with hand eczema: A systematic review and meta-analysisMie Siewertsen, Charlotte Näslund-Koch, Jeanne Duus Johansen, et al.
Acta Dermato-Venereologica|October 13, 2021
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort StudyChristopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, et al.
Acta Dermato-Venereologica|November 21, 2023
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Daniel Isufi, et al.
Frontiers in Immunology|January 4, 2024
Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasisMaría Teresa Martín Monreal, Amanda Kvist-Hansen, Laura Massarenti, et al.
JAMA Dermatology|April 7, 2021
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With PsoriasisNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Dermatology (Basel, Switzerland)|March 3, 2026
Screening practice of cardiovascular risk and psoriatic arthritis among patients with psoriasis in primary careYasmine Khaldi, Lone Skov, Claus Zachariae, et al.
Dermatologic Therapy|August 21, 2021
Effectiveness of brodalumab after previous treatment failure of interleukin-17A inhibitors in patients with psoriasisNikolai Loft, Anne Bregnhøj, Simon Fage, et al.
International Journal of Dermatology|October 29, 2025
Risk of Dyslipidemia Associated With Oral Janus Kinase Inhibitors: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled TrialsDaniel Isufi, Niloufar Javanmardi, Mikkel Bak Jensen, et al.
International Journal of Molecular Sciences|September 27, 2025
The Association Between Genetics and Response to Treatment with Biologics in Patients with PsoriasisNikolai Loft, Sule Altintas, Rownaq Al-Sofi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 29, 2024
Psychological burden, anxiety, depression and quality of life in patients with hand eczema: A systematic review and meta-analysisMie Siewertsen, Charlotte Näslund-Koch, Jeanne Duus Johansen, et al.
Acta Dermato-Venereologica|October 13, 2021
Predictors of Response to Biologics in Patients with Moderate-to-severe Psoriasis: A Danish Nationwide Cohort StudyChristopher Willy Schwarz, Nikolai Loft, Mads Kirchheiner Rasmussen, et al.
Acta Dermato-Venereologica|November 21, 2023
Response to Interleukin-17A Inhibitors According to Prior Biologic Exposures: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Daniel Isufi, et al.
Frontiers in Immunology|January 4, 2024
Characterization of circulating extracellular traps and immune responses to citrullinated LL37 in psoriasisMaría Teresa Martín Monreal, Amanda Kvist-Hansen, Laura Massarenti, et al.
JAMA Dermatology|April 7, 2021
Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With PsoriasisNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Acta Dermato-Venereologica|December 15, 2020
Response to Biologics During the First Six Months of Therapy in Biologic-naïve Patients with Psoriasis Predicts Risk of Disease Flares: A Danish Nationwide StudyNikolai Loft, Alexander Egeberg, Mads Kirchheiner Rasmussen, et al.
Pageof 4